Navigation Links
Anti-Cholesterol Drugs Help Prevent Lung Decline

Statins might fight deadly pulmonary disease, experts say

FRIDAY, Oct. 12 (HealthDay News) -- Statin drugs used to lower blood cholesterol also slow the lung function loss that inevitably occurs with age and often is exacerbated by disease or smoking, researchers report.

The Harvard study included a group of more than 800 people who had their lung function measured at least twice between 1995 and 2005.

Those who were taking statins to improve their cholesterol lost lung function at about half the rate of those not using the drugs, the team reported.

"The effect was larger than I thought we would find," said Joel Schwartz, professor of environmental epidemiology at the Harvard School of Public Health, and lead author of the study, which was published in the American Journal of Respiratory and Critical Care Medicine.

In measurements of "FEV1" -- the amount of air a person can expel from the lungs in one second -- statin users lost an average of 10.9 milliliters capacity per year, compared to 23.9 milliliters annually for nonusers.

In a different measure of lung function, called forced vital capacity, statin users lost an average of 14 milliliters per year, while the loss for nonusers averaged 36.2 milliliters annually.

"It has become clear in the last five years that, in addition to lowering cholesterol, statins are potent antioxidants and reduce inflammation," Schwartz said. "Those effects are important in preventing lung function decline."

The results closely traced those of a study reported a year ago by researchers at the University of Oklahoma Medical Center. In that trial, 238 participants who took statins experienced a decline in FEV1 of 2.5 percent over an average follow-up of 2.7 years, compared to a loss averaging 12.8 percent over the same period for those not on the drugs.

That study's lead author, associate professor of medicine Dr. Jean I. Keddissi, believes the benefit stems from statins' anti-inflammatory action.

"Inflammation plays an important role in lung disease, so there is a huge potential for therapy in lung diseases such as emphysema and chronic obstructive pulmonary disease," Keddissi said.

The two trials do not yet provide nearly enough information to warrant routine use of statin therapy for lung disease, however.

"Where you go from here is a controlled clinical trial," Schwartz said. "I would think that a clinical trial doesn't seem like a risky thing, and it would get support. There are a lot of people interested in selling statins."

The potential of statin treatment seems great for chronic obstructive pulmonary disease, which affects an estimated 20 million Americans, Keddissi said.

"We have no effective treatments for COPD now," Keddissi noted. "Only bronchodilators at the start, and then oxygen."

"I wouldn't put anyone on statins at this point if they had lung disease," Keddissi said. But the Oklahoma group is taking a first step toward the use of these medications for lung trouble. "We are starting some work here in Oklahoma City, studying people with chronic obstructive pulmonary disease with statins," Keddissi said.

More information

For more on statins, head to the U.S. National Heart, Lung and Blood Institute.

SOURCES: Joel Schwartz, Ph.D., professor, environmental epidemiology, Harvard School of Public Health, Boston; Jean I. Keddissi, M.D., associate professor, medicine, University of Oklahoma Medical Center, Oklahoma City; October 2007, American Journal of Respiratory and Critical Care Medicine

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Anti-cholesterol Statins May Be Helpful For Eyes Too
2. Lean Protein Could Be Key to Obesity Drugs
3. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Cancer drugs in development nearly doubled since 1995
6. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
7. African HIV strains more resistant to anti HIV drugs
8. Emphasis to ban Drugs ads by Doctors
9. Drugs said to Reduce HIV Transmission to Baby
10. Cholesterol Drugs Prevent Breast Cancer
11. Risky Drugs To Be Avoided In The Elderly
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. This is one of Joplin's most famous and beautiful concert posters. The concert ... Michigan in Ann Arbor. The According to Hawley, "It is hard to believe that ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: